NMRA vs WH · $283.5M cap vs P/E 20, rev $1.41B
Neumora Therapeutics, Inc. (NMRA) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported WH revenue for 2024-12-31 was $1.41B. Net income was $289.0M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. WH currently screens at market cap $6.51B and trailing P/E 20.1.
NMRA currently screens at market cap $283.5M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the NMRA and WH stock pages for the full models.
Not investment advice.